This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Lung Cancer Survivors Share Stories Of Value Of Early Detection And Hope For More Effective Treatments





Lung Cancer Awareness Month is National Reminder

WASHINGTON, Nov. 2, 2012 /PRNewswire-USNewswire/ -- Lung cancer survivors from across the nation have joined together through LUNGevity Foundation to share their stories and educate the public about lung cancer, the nation's number one cancer killer that affects one in 14 Americans. The survivors demonstrate the hope that science offers for more effective lung cancer treatments and the importance of early detection. Throughout the year, but especially during November, national Lung Cancer Awareness Month, those touched by lung cancer seek to build public awareness of the disease and the need for critical research funds. LUNGevity Foundation, the nation's largest lung cancer- focused nonprofit, funds the most promising research for the early detection and successful treatment of lung cancer, and provides information, resources and a community to patients and caregivers.

"Progress in lung cancer research is giving us reason to be hopeful," said LUNGevity Foundation President Andrea Stern Ferris. "During Lung Cancer Awareness Month, and throughout the year, creating greater awareness and visibility of the disease is critical. Despite being the nation's number one cancer killer, lung cancer receives relatively little government research funding, and LUNGevity is working to fill this gap. As our spokespeople reflect, anyone can be affected by lung cancer, regardless of age, race, ethnicity or smoking history. I hope their stories help people understand both the impact of lung cancer and the need for investing in science to help those affected." 

The past decade has seen significant research-based advances in early detection and therapeutics for lung cancer patients. The 2011 National Cancer Institute's National Lung Screening Trial showed the importance of detecting lung cancer early, and for the first time established a screening approach for a high-risk population. Progress is being made in research for the development of blood biomarkers, genome sequencing capabilities and molecular and imaging technologies to help detect the disease. Targeted therapies are greatly improving the treatment experience, including quality of life, for some lung cancer patients, and progress is being made in both immunotherapy and antiangiogenic therapy (cutting off the blood supply to lung cancer tumors).

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,172.68 -107.06 -0.62%
S&P 500 1,994.29 -16.11 -0.80%
NASDAQ 4,527.6890 -52.10 -1.14%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs